Compare AstraZeneca plc (AZN) vs PubMatic Inc (PUBM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs PubMatic Inc — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while PubMatic Inc trades at $17.52 (market cap $804.41M). The key difference: AstraZeneca plc is far larger — about 308.5× PubMatic Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while PubMatic Inc pays none. Which is the better fit depends on your goals.
| AZN | PUBM | |
|---|---|---|
Market Cap | $248.14B | $804.41M |
Sector | Health | Technology |
52-Week High | $209.48 | $17.78 |
52-Week Low | $147.06 | $6.28 |
Enterprise Value | $275.41B | $707.54M |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About PubMatic Inc
PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →
